Harvard Business Case
About Erik van den Berg
Erik has over twenty years’ experience in the pharmaceutical and biotechnology industries. He joined AM-Pharma in September 2007 as Chief Business Officer and became the company’s CEO in 2011.
Previously, as a Senior Executive at Organon (NL) he was responsible for leading the Company’s global biotechnology business development.
Prior to joining Organon, Erik worked in business and corporate development at the biotechnology company IsoTis, and as a Management Consultant at Arthur D. Little. Erik is board member at Lava Therapeutics, Step Pharma, Lead Pharma, Heatmatrix Group and the Dutch biotechnology association.
Erik has an MSc in Chemistry from the University of Utrecht (NL) and an MBA from Manchester Business School (UK) both with distinction.
Jumpstart your career
Join BioBusiness Summer School to jumpstart your career in Life Sciences by gaining knowledge of business aspects such as product development, IPR, finance and business models. The next edition of the summer school will take place from 28 June to 2 July 2021!
The BioBusiness Summer School is a programme tailored to bridge the gap. By immersing yourself in the business aspects of Life Sciences during this programme, you will learn the basic knowledge of BioBusiness, gain insight in the world of Life Sciences companies, meet leading business leaders and increase your international network.